A big reshuffle has been made in one of the principal guidelines for Commissioning & Qualification (C&Q) within the pharmaceutical industry today. The changes seek to improve the application of Quality Risk Management (QRM), a growing element of regulatory expectation…
https://kenx.org/wp-content/uploads/2020/08/insight-photo.png293766Evan HThttps://kenx.org/wp-content/uploads/2020/07/Insights-Logo22-1.pngEvan HT2020-09-02 14:35:342022-01-18 21:46:14The Big Reshuffle — Impact Assessments and System Criticality
Since the publication of ICH Q9[1] in 2005, the pharmaceutical industry is encouraged to take a risk-based approach to the control and management of product quality. The expectation that Quality Risk Management (QRM) is integrated into the Pharmaceutical Quality System (PQS) is further developed in ICH Q10 [2]. ICH Q10 objectives are to achieve…
https://kenx.org/wp-content/uploads/2020/07/unnamed.png4861128rculverhttps://kenx.org/wp-content/uploads/2020/07/Insights-Logo22-1.pngrculver2020-07-07 15:10:002020-07-30 05:13:21Risk Management Tied Up With A Bow Tie
The Big Reshuffle — Impact Assessments and System Criticality
A big reshuffle has been made in one of the principal guidelines for Commissioning & Qualification (C&Q) within the pharmaceutical industry today. The changes seek to improve the application of Quality Risk Management (QRM), a growing element of regulatory expectation…
Risk Management Tied Up With A Bow Tie
Since the publication of ICH Q9[1] in 2005, the pharmaceutical industry is encouraged to take a risk-based approach to the control and management of product quality. The expectation that Quality Risk Management (QRM) is integrated into the Pharmaceutical Quality System (PQS) is further developed in ICH Q10 [2]. ICH Q10 objectives are to achieve…